DWP14012

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

TreatmentGastric Ulcer

332 competitors in Treatment

#DrugCompanyPhaseTrials

1

DWP14012

Daewoong Pharmaceutical Co. LTD.

Phase 3

22

Levulan

Sun Pharmaceutical Industries, Inc.

Preclinical

13

Lamprene

Novartis

Preclinical

14

Emtriva

Gilead

Preclinical

15

Hivid

CConrado Roberto Hoffmann Filho

Preclinical

66

Foscavir

CClinigen, Inc.

Preclinical

67

Valium

Akero Therapeutics

Preclinical

28

Clomid

Ferring

Preclinical

19

Aurlumyn

BBTG International Inc.

Preclinical

110

Reminyl

WWim Janssens

Preclinical

1Show 28 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Tics5 trials

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of After Administrations of DWP14012 Alone and Combinations of DWP14012, Clarithromycin and Amoxicillin in Healthy Male Subjects

Completed·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT03487562·48 enrolled

Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (II)

Unknown status·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT04167267·24 enrolled

Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers

Unknown status·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT04003441·24 enrolled

Show 2 more trials

Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (III)

Unknown status·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT04185805·24 enrolled

Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects

Completed·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT05149274·32 enrolled

Gastroesophageal Reflux Disease3 trials

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)

Completed·Daewoong Pharmaceutical Co. LTD.·Phase 2·NCT03184324·211 enrolled

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3)

Completed·Daewoong Pharmaceutical Co. LTD.·Phase 3·NCT03736369·263 enrolled

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD)

Unknown status·Daewoong Pharmaceutical Co. LTD.·Phase 3·NCT06121830·324 enrolled

Treatment2 trials

Treatment Effect According to Timing of Administration of DWP14012 40 mg

Unknown status·KKonkuk University Medical Center·N/A·NCT04888819·186 enrolled

Treatment Effect According to Timing of Administration of DWP14012 40 mg

Unknown status·Daewoong Pharmaceutical Co. LTD.·N/A·NCT04613895·186 enrolled

Interaction2 trials

Pharmacokinetic Interaction Between DWP14012 and DWC202005 in Healthy Volunteers

Completed·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT04328766·36 enrolled

Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDs

Unknown status·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT04490434·110 enrolled

Oral2 trials

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers

Completed·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT02757144·120 enrolled

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Japanese, Caucasian and Korean

Completed·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT03574415·80 enrolled

10 more indications

Efficacy and Safety2 trials

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non Erosive Reflux Disease

Unknown status·Daewoong Pharmaceutical Co. LTD.·Phase 3·NCT03811080·327 enrolled

Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori

Completed·Daewoong Pharmaceutical Co. LTD.·Phase 3·NCT06751121·461 enrolled

Esophagitis2 trials

The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis

Completed·Daewoong Pharmaceutical Co. LTD.·Phase 3·NCT05813561·332 enrolled

Study to Evaluate the Efficacy and Safety of DWP14012 on Maintaining Healing in Subjects With Healed Erosive Esophagitis

Unknown status·Daewoong Pharmaceutical Co. LTD.·Phase 3·NCT04341428·406 enrolled

Intravenous2 trials

Study to Evaluate the Safety/Tolerability, PK and PD After Intravenous DWJ1521 Administration in Healthy Volunteers

Completed·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT06508645·33 enrolled

Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics After Intravenous DWJ1521 Administration in Healthy Adult Volunteers

Unknown status·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT04827472·36 enrolled

Drug Interactions2 trials

Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects

Completed·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT05304845·24 enrolled

Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects

Completed·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT05574374·36 enrolled

Chronic Gastritis1 trial

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis

Completed·Daewoong Pharmaceutical Co. LTD.·Phase 3·NCT04341454·327 enrolled

Clinical Trial1 trial

Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects

Unknown status·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT05812404·36 enrolled

Peptic ulcer1 trial

Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer

Completed·Daewoong Pharmaceutical Co. LTD.·Phase 3·NCT04784910·423 enrolled

Erosive Esophagitis1 trial

A Multi-center, Double-blind, Randomized, Active-controlled, Parallel-group, Phase III Clinical Trial and Open-label Extension Study to Evaluate the Efficacy and Safety of DWP14012 for Maintenance Therapy in Patients With Healed Erosive Esophagitis

Not yet recruiting·Daewoong Pharmaceutical Co. LTD.·Phase 3·NCT07746518·420 enrolled

Gastric Ulcer1 trial

A Multinational, Multicenter, Randomized, Double-blind, Active-controlled, Parallel-group, Phase 3 Study to Evaluate the Efficacy and Safety of DWP14012 in Participants With Gastric Ulcer

Not yet recruiting·Daewoong Pharmaceutical Co. LTD.·Phase 3·NCT07730138·384 enrolled

Unspecified1 trial

A Clinical Study to Investigate the Mass Balance and Biotransformation of [14C]DWP14012 in Healthy Chinese Male Subjects

Unknown status·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT05868967·8 enrolled

Details

Drug Info

Related News